{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:23:47Z","timestamp":1791563027811,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.oret.2025.04.021","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:51:51Z","timestamp":1746726711000},"page":"1071-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Visual Field Changes in Diabetic Retinopathy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-134X","authenticated-orcid":false,"given":"Debora H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-4042","authenticated-orcid":false,"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-1772","authenticated-orcid":false,"given":"Tiarnan D.L.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cukras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.04.021_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bjo.47.10.611","article-title":"Visual prognosis of proliferating diabetic retinopathy","volume":"47","author":"Beetham","year":"1963","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/diab.16.10.728","article-title":"Prognosis of proliferative retinopathy in juvenile diabetics","volume":"16","author":"Deckert","year":"1967","journal-title":"Diabetes"},{"key":"10.1016\/j.oret.2025.04.021_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/diab.17.3.121","article-title":"Diabetic retinopathy. A further study of prognosis for vision","volume":"17","author":"Caird","year":"1968","journal-title":"Diabetes"},{"key":"10.1016\/j.oret.2025.04.021_bib4","first-page":"583","article-title":"Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group","volume":"88","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib5","first-page":"766","article-title":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib6","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic retinopathy preferred practice pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Writing Committee for the Diabetic Retinopathy Clinical Research Network","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.04.021_bib8","first-page":"1145","article-title":"Long-term effects of ranibizumab on diabetic retinopathy severity and progression","volume":"130","author":"Ip","year":"2012","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.oret.2025.04.021_bib9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2025.04.021_bib10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","article-title":"Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections","volume":"125","author":"Obeid","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2018.07.027","article-title":"Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor","volume":"126","author":"Obeid","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib13","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaophthalmol.2019.4284","article-title":"Five-year cost-effectiveness of intravitreous ranibizumab therapy vs panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial","volume":"137","author":"Hutton","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archopht.1984.01040031044020","article-title":"Retinal microangiopathy. Correlation of OCTOPUS perimetry with fluorescein angiography","volume":"102","author":"Bell","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bjo.77.11.726","article-title":"Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy","volume":"77","author":"Chee","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajo.2007.07.011","article-title":"Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy","volume":"144","author":"Unoki","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.visres.2010.08.024","article-title":"Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy","volume":"51","author":"van Dijk","year":"2011","journal-title":"Vision Res"},{"key":"10.1016\/j.oret.2025.04.021_bib18","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.2337\/db13-1628","article-title":"Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study","volume":"63","author":"Hellgren","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.oret.2025.04.021_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1755-3768.1994.tb07180.x","article-title":"Visual fields at different stages of diabetic retinopathy","volume":"72","author":"Henricsson","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaophthalmol.2019.5939","article-title":"Visual field changes over 5 years in patients treated with panretinal photocoagulation or ranibizumab for proliferative diabetic retinopathy","volume":"138","author":"Maguire","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib21","first-page":"1","article-title":"Diabetic Retinopathy Study Report Number 6. Design, Methods, and baseline results","volume":"21","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.04.021_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0161-6420(81)34983-5","article-title":"Midperipheral fundus involvement in diabetic retinopathy","volume":"88","author":"Shimizu","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ophtha.2015.01.008","article-title":"Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","article-title":"Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib25","doi-asserted-by":"crossref","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.oret.2025.04.021_bib26","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1167\/iovs.08-3143","article-title":"Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy","volume":"50","author":"van Dijk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.04.021_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-9394(98)00309-2","article-title":"Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group","volume":"127","author":"Fong","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.1987.01060060093040","article-title":"Intraocular pressure following panretinal photocoagulation for diabetic retinopathy: diabetic retinopathy report no. 11","volume":"105","author":"Kaufman","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib29","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1167\/iovs.05-1141","article-title":"Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings","volume":"47","author":"Vujosevic","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.04.021_bib30","first-page":"805","article-title":"Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema","volume":"20","author":"Okada","year":"2006","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.oret.2025.04.021_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000310094","article-title":"Assessment of visual-field changes before and after focal photocoagulation for clinically significant diabetic macular edema","volume":"200","author":"Sims","year":"1990","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2025.04.021_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.04.021_bib33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ophtha.2014.03.021","article-title":"Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00417-007-0678-2","article-title":"Role of retinal hypoxia in diabetic macular edema: a new concept","volume":"246","author":"Hayreh","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib35","doi-asserted-by":"crossref","DOI":"10.34172\/jlms.2022.40","article-title":"Conventional and pattern scanning pan-retinal photocoagulation laser in diabetic patients\u2019 visual field","volume":"13","author":"Hassanpoor","year":"2022","journal-title":"J Lasers Med Sci"},{"key":"10.1016\/j.oret.2025.04.021_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0161-6420(89)32924-1","article-title":"Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation","volume":"96","author":"Morgan","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.1991.01080110085041","article-title":"Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema","volume":"109","author":"Schatz","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00006982-200408000-00002","article-title":"Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy","volume":"24","author":"Maeshima","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.04.021_bib39","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.oret.2025.04.021_bib40","first-page":"913","article-title":"VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats","volume":"118","author":"Li","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.oret.2025.04.021_bib41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ophtha.2016.05.037","article-title":"Cost evaluation of panretinal photocoagulation versus intravitreal ranibizumab for proliferative diabetic retinopathy","volume":"123","author":"Lin","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.04.021_bib42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamaophthalmol.2017.0837","article-title":"Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy: secondary analysis from a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial","volume":"135","author":"Hutton","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/IAE.0b013e31819d2591","article-title":"Infectious endophthalmitis after intravitreal injection of antiangiogenic agents","volume":"29","author":"Diago","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.04.021_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.04.021_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fneur.2016.00049","article-title":"Nutrition and vascular supply of retinal ganglion cells during human development","volume":"7","author":"Rutkowski","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.oret.2025.04.021_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaophthalmol.2018.4982","article-title":"Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy","volume":"137","author":"Aiello","year":"2019","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T02:45:44Z","timestamp":1763779544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025002088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2468653025002088"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.04.021","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Field Changes in Diabetic Retinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}